ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

NewsGuard 100/100 Score

D3 Radiation Services announced today  that the American Board of Radiology (ABR) has qualified eDataAudit--a new service designed to reduce errors in the delivery of radiation therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of Certification (MOC).

With eDataAudit , participating clinics and radiation oncology physicists can order a comprehensive audit of their beam data through the use of a web portal: http://www.d3cdms.com. "This is a unique service that addresses a major recommendation of the American Association of Physicists in Medicine (AAPM) TG-106 report requiring beam data to be audited prior to going clinical," said Nabil Adnani, Ph.D., DABR, Chief Products Development Officer at D3 Radiation Services.

According to reports by international organizations such as the International Atomic Energy Authority and the World Health Organization, the majority of reported adverse events in radiation oncology can be traced back to errors committed during linear accelerator commissioning. More recently, the Radiological Physics Center (RPC) at M.D. Anderson Cancer Center published a report about the problems of credentialing radiation oncology clinics to participate in National Cancer Institute sponsored clinical trials. According to the center, approximately three out of 10 participating clinics failed their credentialing efforts, with the majority of the failures traceable to commissioning errors.

"With ABR's approval, eDataAudit will not only help minimize these errors but also provide reports that participating physicists can use to fulfill the 4th component of the ABR's Maintenance Of Certification requirements," Dr. Adnani noted.

Attendees of the 52nd AAPM Annual Meeting in Philadelphia on July 18th – 22 can learn more about eDataAudit by visiting D3's exhibit booth #731.

SOURCE D3 Radiation Services

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels